![]() Innovation Pharmaceuticals Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications. | ![]() MediWound MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care. | Angion Biomedica Angion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury. | ![]() Epirium Bio Epirium Bio is a company that develops therapeutics designed to promote mitochondrial biogenesis and function. | ![]() Protego Biopharma Protego Biopharma is a preclinical-stage biotechnology company that develops pharmacological chaperone screening platforms. | |
Founding Date | Founding Date 2007 | Founding Date 2001 | Founding Date 1998 | Founding Date 2008 | Founding Date 2011 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Wakefield, US HQ Beverly, US | Locations Yavne, IL HQ Rüsselsheim Am Main, DE Wilmington, US | Locations San Francisco, US HQ Uniondale, US | Locations San Diego, US HQ San Diego, US | Locations San Diego, US HQ |
Employees | Employees 450% decrease | Employees 111 | Employees 205% increase | Employees 14 | Employees 25 |
Valuation ($) | Valuation ($) 1 m | Valuation ($) 196.3 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $17m (FY, 2025) | Revenue (est.) $2.3m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($3.2m) (FY, 2023) | Net income ($23.9m) (FY, 2025) | Net income ($38.8m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 15.4m (almost 8 years ago) | Latest funding round $ 85m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 19.7m | Total funding raised $ 85m | Total funding raised N/A |

MediWound is a biotechnology company engaged in developing innovative solutions in severe burn and chronic wound care.
View companyAngion Biomedica Corp is a biopharmaceutical company focused on acute kidney injury, acute lung injury, and CNS injury.
View company
Epirium Bio is a company that develops therapeutics designed to promote mitochondrial biogenesis and function.
View company
Protego Biopharma is a preclinical-stage biotechnology company that develops pharmacological chaperone screening platforms.
View company